BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35129148)

  • 21. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
    Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
    J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraneural metastasis in intracranial tumors in children: the experience of a single center.
    Varan A; Sari N; Akalan N; Söylemezoğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    J Neurooncol; 2006 Sep; 79(2):187-90. PubMed ID: 16645723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation.
    Song L; Wang S; Fang T; Qiu X; Wang X; Zhou X; Morse MA; Hobeika A; Wu W; Yang H; Ren J; Lyerly HK
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):479-490. PubMed ID: 33974888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
    Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
    Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
    Leary SES; Kilburn L; Geyer JR; Kocak M; Huang J; Smith KS; Hadley J; Ermoian R; MacDonald TJ; Goldman S; Phillips P; Young Poussaint T; Olson JM; Ellison DW; Dunkel IJ; Fouladi M; Onar-Thomas A; Northcott PA
    Neuro Oncol; 2022 Jul; 24(7):1178-1190. PubMed ID: 34935967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
    Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
    Becher OJ; Millard NE; Modak S; Kushner BH; Haque S; Spasojevic I; Trippett TM; Gilheeney SW; Khakoo Y; Lyden DC; De Braganca KC; Kolesar JM; Huse JT; Kramer K; Cheung NV; Dunkel IJ
    PLoS One; 2017; 12(6):e0178593. PubMed ID: 28582410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
    Sanai N; Polley MY; Berger MS
    J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors.
    Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and Spinal Cord Tumors of Embryonic Origin.
    Lampros M; Alexiou GA
    Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
    Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
    Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation.
    Panosyan EH; Laks DR; Masterman-Smith M; Mottahedeh J; Yong WH; Cloughesy TF; Lazareff JA; Mischel PS; Moore TB; Kornblum HI
    Pediatr Blood Cancer; 2010 Oct; 55(4):644-51. PubMed ID: 20589659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
    Tringale KR; Wolden SL; Casey DL; Kushner BH; Luo L; Pandit-Taskar N; Souweidane M; Cheung NV; Modak S; Basu EM; Kramer K
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30075. PubMed ID: 36349892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in pediatric CNS tumors in Armenia: a multicenter retrospective study.
    Hoveyan J; Asatryan E; Grigoryan H; Hovsepyan S; Avagyan A; Hakobyan L; Sargsyan L; Iskanyan S; Avagyan M; Hovhannisyan S; Melnichenko I; Minasyan M; Papyan R; Manukyan N; Lazaryan A; Danelyan S; Muradyan A; Arakelyan J; Qaddoumi I; Boop F; Mkhitharyan A; Harutyunyan M; Tamamyan G; Bardakhchyan S
    Childs Nerv Syst; 2024 Feb; 40(2):435-444. PubMed ID: 37837453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
    Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
    Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.
    Cacciotti C; Choi J; Alexandrescu S; Zimmerman MA; Cooney TM; Chordas C; Clymer J; Chi S; Yeo KK
    J Neurooncol; 2020 Aug; 149(1):113-122. PubMed ID: 32627129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
    Cotter JA; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
    Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
    Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.